Introduction
Human neurodegenerative disorders are characterized by pathological tissue injury with permanent loss of resident cells in the nervous system. Alzheimer's disease (AD; see Glossary), Parkinson's disease (PD) and Huntington's disease (HD) are major causes of disability in the United States with current therapy limited to symptomatic treatments, supporting the potential utility of cell-based therapies. NSCs are functionally defined by their ability for sustained self-renewal and proliferation with multipotency towards central nervous system (CNS) lineages, being able to generate mature neurons, astrocytes or oligodendrocytes both in vitro and in vivo to populate a tissue during development or injury response [1, 2] . With greater lineage commitment, NPCs display partial differentiation and enhanced proliferation to specific fates, for example neuroblasts or oligodendrocyte progenitor cells (OPCs) [1, 2] . Owing to their ability to repopulate tissues, both NSCs and NPCs have been considered as attractive sources for the development of cell-based therapies [3] . Thus, it will be essential to identify key molecular signals responsible for NSC-NPC biology to inform treatment of neurodegenerative diseases.
Chemokines represent a superfamily of small chemotactic cytokines that are commonly secreted. Chemokines control cellular motility during development, normal homeostasis, and injury responses [4] . Chemokines are classified into the four subfamilies, CXC, CC, C, and CX3C, based on conserved cysteine residues near the N-terminus [5, 6] . CXCL12 [(also known as pre-B cell growth-stimulating factor (PBSF) or stromal cell-derived factor (SDF-1)] belongs to the CXC subfamily [7] . CXCL12 is classically defined as a regulatory signal for peripheral hematopoietic stem cells (HSCs) [8] , but CXCL12 also serves to maintain embryonic and adult NSCs [9] [10] [11] . Considering the vital roles of NSCs during tissue repair, CXCL12 is predicted to contribute to the recruitment of NSCs to damaged regions to enhance recovery. Consistent with this hypothesis, blood vessels within damaged tissues release CXCL12 [12] [13] [14] [15] .
Review

Glossary
Alzheimer's disease (AD): the most common neurodegenerative disorder, which primarily affects older adults. The main clinical manifestations of AD are learning and selective memory impairment due to neuronal death. The pathogenesis of AD is related to the extracellular deposits of Ab, also known as neuritic plaques. Chemokines: chemotactic cytokines that functionally guide the migration of leukocytes during normal and inflammatory conditions. Most (if not) all chemokines are small (8-10 kDa) secreted proteins, that are classified into four subfamilies (CXC, CC, C, or CX3C). Binding of chemokines to their receptors (GPCRs) induces G protein-mediated signaling pathways. Demyelinating diseases: these are caused by the loss of mature oligodendrocytes that normally provide the myelin sheath to protect neuron axons in the CNS. Occurrence of pathological demyelination is due to many factors, including genetic mutations, infection, inflammation, and chemical toxicity. Experimental autoimmune encephalomyelitis (EAE): an animal model for human CNS inflammation. Neuroinflammation-mediated demyelination is the major pathological change in both brain and spinal cord. G protein-coupled receptors (GPCRs): seven-transmembrane (7TM) domain receptors. Binding of ligand to a GPCR can induce G protein-mediated downstream signaling pathways. A G protein is composed of a, b and g subunits. G protein-mediated pathways directly depend on the a subunit involved (e.g., Gas, Gai/o, Gaq/11, Ga12/13). 
